Qatar Investment Authority in BridgeBio Pharma, Inc.
Announced. First disclosed September 25, 2023, in an issuer or fund release (source).
- Investor
- Qatar Investment Authority (Qatar)
- Investor as named in source
- Qatar Investment Authority (QIA)
- Target
- BridgeBio Pharma, Inc.
- Target country
- United States
- Sector
- Health and Life Sciences
- First disclosed
- September 25, 2023, Issuer or fund release
- Amount
- $250.0 million
- Stake at first disclosure
- Not stated
- Source text
… $250 million financing led by Qatar Investment Authority (QIA) with significant participation from four of the largest investment management firms in the US …
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| September 25, 2023 | BridgeBio Pharma, Inc. release | Not applicable | View |
Cite: Middle East Forum, “Qatar Investment Authority in BridgeBio Pharma, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/qia-bridgebio-pharma-inc/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.